常规疗法加黄芪注射液治疗肺心病并心衰及呼衰51例观察

Observation on Heart-Respiratory Failure of Pulmonary Heart Disease(51 cases) Treated with Routine Treatment and Astragalus Injection

常规疗法加黄芪注射液治疗肺心病并心衰及呼衰５１例（Ａ组），另单用常规疗法治疗３８例（Ｂ组），结果：Ａ总有效率较 Ｂ组有非常显著性差异（Ｐ＜０．０１）；治疗前后的动脉血二氧化碳分压降低和氧分压提高，Ａ组较Ｂ组分别有非常显著差异（Ｐ＜０.０１）和显著性差异（Ｐ＜０．０５）；Ａ组的平均疗效时间较Ｂ组明显缩短，且有显著性差异（Ｐ＜０．０５）。提示常规疗法加黄芪注射液可明显改善肺心病并心衰及呼衰患者的心功能和呼吸功能，疗效优于单用常规疗法。

Routine treatment combined with astragalus injection has been applied to treat 51 cases of heart -respiratory failure of pulmonary heart disease(group A), while simple routine treatment to treat 38 cases as contrast(group B). The result showed that the total effective rate is significant difference between A and B(P< 0.01); the dicreased PaCO2 and the increased PaO2 in artery blood are significant(P<0. 01) and highly signifiant difference(p<0. 001) between A and B. It is suggested that the effect of routine treatment combined with astragalus injection is better than that of simple routine treatment in improving heart-respiratory failure.